TLR7/9 Antagonists as Therapeutics for Immune-Mediated Inflammatory Disorders

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 6, Iss. 4, 2007-12 ,pp. : 223-235

Bentham Science Publishers

Access to resources Recommend Favorite

Rho Kinase (ROCK) Inhibitors and Their Application to Inflammatory Disorders

By  

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 8, 2009-05 ,pp. : 704-723

Bentham Science Publishers

Access to resources Recommend Favorite

Protein Kinase C-theta Inhibitors: A Novel Therapy for Inflammatory Disorders

By  

Current Pharmaceutical Design, Vol. 18, Iss. 30, 2012-10 ,pp. : 4725-4746

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacological modulation of adenosine receptor pathways and inflammatory disorders: the way towards novel therapeutics?

By Antonioli Luca   Fornai Matteo   Colucci Rocchina   Tuccori Marco   Blandizzi Corrado  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 6, 2011-06 ,pp. : 717-721

Informa Healthcare

Access to resources Recommend Favorite

Thymidine Kinase-Mediated Shut Down of Bone Morphogenetic Protein-4 Expression Allows Regulated Bone Production

By  

Current Gene Therapy, Vol. 13, Iss. 3, 2013-06 ,pp. : 202-210

Bentham Science Publishers

Access to resources Recommend Favorite